Application of carnosol as inhibitor of inflammasomes
A technology of carnosol and inflammasome, applied in the field of drug screening
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0030] In order to make the purpose, technical solution and advantages of the application clearer, the embodiments of the application will be described in detail below in conjunction with the accompanying drawings. It should be noted that, in the case of no conflict, the embodiments in the present application and the features in the embodiments can be combined arbitrarily with each other.
[0031] drug:
[0032] Carnosol and MCC950 were purchased from TargetMol; LPS was purchased from Sigma, USA.
[0033] Reagents and materials:
[0034] DMEM medium, fetal bovine serum (U.S. HyClone company); Opti-MEM serum-free medium (U.S. Gibco company); trypsin, double antibody (penicillin-streptomycin solution) (Maichen Technology Beijing Co., Ltd.); adenosine triphosphate ( ATP), nigericin (Nigericin), lipopolysaccharide (LPS), dimethylsulfoxide (DMSO) (Sigma Aldrich, USA); NLRP3, ASC, Caspase-1, pro-Caspase-1, pro-IL1β, GAPDH Antibody (U.S. Cell Signaling Technology Company); CCK-8 k...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com